首页> 美国卫生研究院文献>Journal of Virology >Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo.
【2h】

Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo.

机译:腺相关病毒2型介导的小鼠造血细胞转导具有长期繁殖能力并在体内持续表达人珠蛋白基因。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Adeno-associated virus type 2 (AAV), a nonpathogenic human parvovirus, is gaining attention as a vector for potential use in human gene therapy. We and others have described AAV-mediated beta-globin gene transfer and expression in established human and murine erythroleukemia cell lines in vitro. However, successful AAV-mediated globin gene transduction of hematopoietic stem cells and long-term expression in vivo in progeny cells have not been documented. We report here that infection of murine hematopoietic bone marrow cells ex vivo with a recombinant AAV vector containing the genomic copy of a normal human globin gene followed by transplantation of these cells into lethally irradiated congenic mice resulted in efficient gene transfer into hematopoietic cells with long-term repopulating ability as detected by the presence of the human globin gene sequences in bone marrow and spleen in primary recipient mice for at least 6 months. Long-term expression of the human globin gene was also detected in bone marrow, but not in spleen, in primary recipient mice. Furthermore, in secondary-transplant experiments, we were also able to document the presence as well as expression of the transduced human globin gene in mouse bone marrow for up to 3 months. These results provide further support for potential use of the AAV-based vector system in gene therapy of human hemoglobinopathies in general and sickle-cell anemia and beta-thalassemia in particular.
机译:腺伴随病毒2型(AAV)是一种非致病性人类细小病毒,作为潜在用于人类基因治疗的载体而受到关注。我们和其他人描述了AAV介导的β-珠蛋白基因在体外建立的人和鼠红白血病细胞系中的转移和表达。但是,尚没有成功的AAV介导的造血干细胞球蛋白基因转导和在子代细胞中体内长期表达的报道。我们在这里报告说,用含有正常人珠蛋白基因的基因组拷贝的重组AAV载体离体感染鼠类造血骨髓细胞,然后将这些细胞移植到经致死性照射的同系小鼠中,可有效地将基因转移到具有长链球菌的造血细胞中通过在主要受体小鼠的骨髓和脾脏中存在至少2个月的人类球蛋白基因序列来检测该术语的繁殖能力。在原代受体小鼠的骨髓中也检测到了人类珠蛋白基因的长期表达,但在脾脏中未检测到。此外,在二次移植实验中,我们还能够记录小鼠骨髓中长达3个月的转导人珠蛋白基因的存在和表达。这些结果为基于AAV的载体系统在人类血红蛋白病(尤其是镰状细胞性贫血,尤其是β地中海贫血)的基因治疗中的潜在用途提供了进一步的支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号